To further assess the clinical significance of MUC1 and TGF-β signaling crosstalk, we first analyzed the gene expression profiles in high and low MUC1 PDA patient samples registered in the TCGA dataset. This evidence concerns the gene TGFB1 and Patent ductus arteriosus.